How AbbVie Beat Expectations in Q3

AbbVie (NYSE: ABBV) hasn't exactly given investors a lot to get excited about so far in 2020. As of Thursday's close, its shares were down by 9% year to date, lagging well behind the S&P 500 index's performance.

However, the big drugmaker's shareholders now have a reason for at least some enthusiasm. AbbVie reported its third-quarter results before the market opened on Friday. Here are the highlights.

Image Source: Getty Images.

Source Fool.com